Full text loading...
Detection of tumorigenesis in rat bladders with optical coherence tomography
1.The American Cancer Society, 1999 Cancers Figure, http://www.cancer.org/statistics/cff99/selectedcancers.html#urinary.
2.R. S. Cajulis, G. K. Haines , 3rd, D. Frias-Hidvegi, K. McVary, and J. W. Bacus, “Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study,” Diagn. Cytopathol 13, 214–223 (1995).
3.J. L. Pariente, L. Bordenave, P. Michel, M. J. Latapie, D. Ducassou, and M. Le Guillou, “Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma,” J. Urol. 158, 338–341 (1997).
4.J. Landman, Y. Chang, E. Kavaler, M. J. Droller, and B. C. Liu, “Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer,” Urology 52, 398–402 (1998).
5.D. Pode, D. Golijanin, Y. Sherman, P. Lebensart, and A. Shapiro, “Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors,” J. Urol. 159, 389–392 (1998).
6.E. M. Messing and W. Catalona, “Urothelial tumors of the urinary tract,” in Campbell’s Urology, 7th ed., edited by P. C. Walsh, A. B. Retik, E. D. Vaughan, and A. J. Wein (W. B. Saunders Company, 1998), pp. 2327–2410.
7.J. Flamm and S. Dona, “The significance of bladder quadrant biopsies in patients with primary superficial bladder carcinoma,” Eur. Urol. 16, 81–85 (1989).
8.B. Chance, K. Kang, and E. Sevick, “Photon diffusion in breast and brain: spectroscopy and imaging,” Opt. Photonics News 4, 9–13 (1993).
9.M. S. Patterson, J. D. Moulton, B. C. Wilson, K. W. Berndt, and J. R. Lakowicz, “Frequency domain reflectance for the determination of the scattering and absorption properties of tissue,” Appl. Opt. 30, 4474–4476 (1991).
10.M. Rajadhyaksha, M. Grossman, D. Esterowitz, R. Webb, and R. R. Anderson, “In vivo confocal scanning laser microscopy of human skin: Melanin provides strong contrast,” J. Invest. Dermatol. 104, 946–952 (1995).
11.W. Denk, J. W. Piston, and W. W. Webb, “Two-photon molecular excitation in laser scanning microscopy,” Science 248, 73–76 (1990).
12.M. Kriegmair, R. Baumgartner, R. Knuechel, H. Stepp, F. Hofstaedter, and A. Hofstetter, “Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence,” J. Urol. 155, 105–110 (1996).
13.F. Koenig, F. J. McGovern, R. Larne, H. Enquist, K. T. Schomacker, and T. F. Deutsch, “Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid,” J. Urol. 83, 129–135 (1999).
14.F. Koenig, S. Gonzalez, W. M. White, M. Lein, and M. Rajadhyaksha, “Near-infrared confocal laser scanning microscopy of bladder tissue in vivo,” Urology 53, 853–857 (1999).
15.P. So, H. Kim, and I. Kochevar, “Two-photon deep tissue ex vivo imaging of mouse dermal and subcutaneous structures,” Opt. Express 3, 339–350 (1998).
16.J. G. Fujimoto, “Optical coherence tomography: A new view toward biomedical imaging,” Photonics Spectra 32, 114–115 (1998).
17.A. F. Fercher, “Optical coherence tomography,” J. Biomed. Opt. 1, 157–173 (1996).
18.T. A. Boppart, B. E. Bouma, C. Pitris, J. F. Southern, M. E. Brezinski, and J. G. Fujimoto, “In vivo cellular optical coherence tomography imaging,” Nat. Med. 4, 861–865 (1998).
19.D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, C. A. Puliafito, and J. G. Fujimoto, “Optical coherence tomography,” Science 254, 1178–1181 (1991).
20.Y. T. Pan, R. Birngruber, R. Rosperich, and R. Engelhardt, “Optical coherence tomography in turbid tissues: theoretical analysis,” Appl. Opt. 34, 6564–6574 (1995).
21.Y. T. Pan, R. Birngruber, and R. Engelhardt, “Contrast limits of coherence-gated imaging in scattering media,” Appl. Opt. 36, 2979–2986 (1997).
22.J. M. Schmitt and A. Knuettel, “Model of optical coherence tomography of heterogeneous tissue,” J. Opt. Soc. Am. A 14, 1231–1242 (1997).
23.Y. T. Pan, E. Lankenau, J. Welzel, R. Birgruber, and R. Engelhardt, “In vivo optical coherence-gated imaging of biological tissues,” IEEE J. Sel. Top. Quantum Electron. 2, 1029–1034 (1997).
24.G. A. Tearney, M. E. Brezinski, B. E. Bouma, S. A. Boppart, C. Pitris, J. F. Southern, and J. G. Fujimoto, “In vivo endoscopic optical biopsy with optical coherence tomography,” Science 276, 2037–2039 (1997).
25.B. Bouma, G. Tearney, S. Boppart, M. R. Hee, M. Brezinski, and J. G. Fujimoto, “High-resolution optical coherence tomographic imaging using a mode-locked Ti: laser source,” Opt. Lett. 20, 1486–1488 (1995).
26.J. A. Izatt, M. D. Kulkarni, K. Kobayashi, M. V. Sivak, J. K. Barton, and A. J. Welch, “Optical coherence tomography for biodiagnostics,” Opt. Photonics News 8, 44–48 (1997).
27.C. Pitris, M. E. Brezinski, B. E. Bouma, G. J. Tearney, J. F. Southern, and J. G. Fujimoto, “High resolution imaging of the upper respiratory tract with optical coherence tomography: A feasibility study,” Am. J. Respir. Crit. Care Med. 157, 1640–1644 (1998).
28.F. Feldchtein, G. Gelikonov, V. Gelikonov, R. Kuranov, A. Sergeev, N. Gladkova, A. Shakhov, A. Shakhova, L. Snopova, A. Terent’eva, E. Zagainova, Y. Chumakov, and I. Kuznetzova, “Endoscopic applications of optical coherence tomography,” Opt. Express 3, 257–270 (1998).
29.C. A. Jesser, C. A. Jesser, S. A. Boppart, C. Pitris, D. L. Stamper, G. P. Nielsen, M. E. Brezinski, and J. G. Fujimoto, “High resolution imaging of transitional cell carcinoma with optical coherence tomography: feasibility for the evaluation of bladder pathology,” Br. J. Radiol. 72, 1170–1176 (1999).
30.Y. T. Pan and D. L. Farkas, “Non-invasive imaging of living human skin with dual-wavelength optical coherence tomography in two and three dimensions,” J. Biomed. Opt. 3, 446–455 (1998).
31.J. P. Lavelle, G. Apodaca, S. A. Meyers, W. G. Ruiz, and M. L. Zeidel, “Disruption of guinea pig urinary bladder permeability barrier in noninfectious cystitis,” Am. J. Physiol. 274, F205–224 (1998).
32.H. O. Negrete, J. P. Lavelle, J. Berg, S. A. Lewis, and M. L. Zeidel, “Permeability properties of the intact mammalian bladder epithelium,” Am. J. Physiol. 271, F886–894 (1996).
33.R. M. Hicks and J. S. Wakefield, “Rapid induction of bladder cancer in rats with N-methyl-N-nitrosourea. I. Histology,” Chem. Biol. Interact 5, 139–152 (1972).
34.G. D. Steinberg, C. B. Brendler, R. A. Squire, and J. T. Isaacs, “Experimental intravesical therapy for superficial transitional cell carcinoma in a rat bladder tumor model,” J. Urol. 145, 647–653 (1991).
35.J. S. Wakefield and R. M. Hicks, “Bladder cancer and N-methyl-N-nitrosourea. II. Sub-cellular changes associated with a single noncarcinogenic dose of MNU,” Chem. Biol. Interact 7, 165–179 (1973).
36.Y. T. Pan, S. Alrt, R. Birngruber, and R. Engelhardt, “Optical coherence tomography in scattering media: theory and experimental results,” Proc. SPIE 2628, 239–248 (1995).
37.E. Beaurepaire, L. Moreaux, F. Amblard, and J. Mertz, “Combined scanning optical coherence and two-photon-excited fluorescence microscopy,” Opt. Lett. 24, 969–971 (1999).
38.Y.-T. Pan, H.-K. Xie, and G. Fedder, “Endoscopic optical coherence tomography based on a CMOS-MEMS micromirror,” Opt. Lett. (in press).
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Article metrics loading...